TrianglePUBLICATIONS · 23715582
Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2013 Jul 1
- First author
- Demetri GD
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Demetri GD
- type
- Author
- name
- Chawla SP
- type
- Author
- name
- Ray-Coquard I
- type
- Author
- name
- Le Cesne A
- type
- Author
- name
- Staddon AP
- type
- Author
- name
- Milhem MM
- type
- Author
- name
- Penel N
- type
- Author
- name
- Riedel RF
- type
- Author
- name
- Bui-Nguyen B
- type
- Author
- name
- Cranmer LD
- type
- Author
- name
- Reichardt P
- type
- Author
- name
- Bompas E
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Demetri GD
- type
- Author
- name
- Chawla SP
- type
- Author
- name
- Ray-Coquard I
- type
- Author
- name
- Le Cesne A
- type
- Author
- name
- Staddon AP
- type
- Author
- name
- Milhem MM
- type
- Author
- name
- Penel N
- type
- Author
- name
- Riedel RF
- type
- Author
- name
- Bui-Nguyen B
- type
- Author
- name
- Cranmer LD
- type
- Author
- name
- Reichardt P
- type
- Author
- name
- Bompas E
- type
- Author
- bibliography ids
- nci-bib-01c4bd83ae4694672d095824
- book metadata
- content sha256
- bfbda0fe07c4c02ec7647d1adb318e207870c9cb77f9fc5bc6c42178ab4918ff
- document type
- citation
- dois
- 10.1200/JCO.2012.45.5766
- electronic publication date
- display
- 2013 May 28
- precision
- day
- year
- 2013
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:23715582
- immutable id
- pubmed:23715582@bfbda0fe07c4c02ec7647d1adb318e207870c9cb77f9fc5bc6c42178ab4918ff
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 19
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2485-92
- volume
- 31
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 23715582
- provenance
- batch id
- 99e008dabc339d38fd44
- provider
- NCBI PubMed ESummary
- record sha256
- ee0c81fb8496c40f4881e0b4b39e82f4748e20de507b9f3c496e9be01e1744ed
- response sha256
- 804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
- retrieved at
- 2026-09-09T23:46:55.094762+00:00
- publication date
- display
- 2013 Jul 1
- precision
- day
- year
- 2013
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy.
Preserved source evidence · Not medical advice